Lycera is a biopharmaceutical company that seeks to uncover new small molecule therapies for the treatment of autoimmune diseases and cancer. Our approach builds on an in-depth understanding of the orchestration of immune response in disease progression. When working correctly, the immune system can respond aggressively and with precise targeting to eliminate infectious pathogens or cancer cells. Incorrect regulation can cause the immune system to attack healthy tissue as foreign, supporting onset and progression of autoimmune disease while disruption of anti-tumor immune responses can shield cancer cells from the immune system and allow them to proliferate. Lycera is rapidly building a portfolio of selective immune modulators with mechanisms we believe will translate into improved outcomes for patients. With senior leadership and a team of scientists who represent the best of their fields, Lycera has the expertise and insight necessary to develop innovative therapies able to restore immune balance and significantly improve treatment for patients affected by these diseases around the world. Lycera product development programs are enhanced by our established global relationships with many leading chemists, scientists and clinical researchers. We are currently advancing novel small molecule compounds from distinct, yet complementary, areas of research, including immune metabolism, cell signaling and immune cell differentiation.
View Top Employees from LyceraWebsite | http://www.lycera.com |
Revenue | $6 million |
Funding | $96.2 million |
Employees | 15 (11 on RocketReach) |
Founded | 2006 |
Address | 1350 Highland Dr, Ann Arbor, Michigan 48108, US |
Phone | (734) 233-3060 |
Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Pharmaceuticals, Biopharma, Healthcare, Drug Manufacturing & Research, Health Care, Science and Engineering, Pharmaceutical |
Web Rank | 6 Million |
Keywords | Can An Organic Chemist Work As Cmc, Responsibilities Of External Cmc Development |
Competitors | BioCryst Pharmaceuticals, Inc., Orphazyme A/S, Plexxikon Inc., Ruthigen, Inc., Yaupon Therapeutics, Inc |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Lycera employee's phone or email?
The Lycera annual revenue was $6 million in 2023.
Sandy Hurd is the Director of Chemical Development of Lycera.
11 people are employed at Lycera.
Lycera is based in Ann Arbor, Michigan.
The NAICS codes for Lycera are [32541, 32, 3254, 325].
The SIC codes for Lycera are [283, 28].